A 28-week, randomized, double-blind, placebo-controlled, efficacy trial of Acetyl-L-carnitine in dementia patients
Latest Information Update: 24 Oct 2019
At a glance
- Drugs Levacecarnine (Primary)
- Indications Cerebrovascular disorders; Dementia
- Focus Therapeutic Use
Most Recent Events
- 24 Oct 2019 New trial record